Letrozole

Trade Name: 
Femara
Manufacturer/Distributor: 
Novartis (1-877-631-6775)
www.novartis.ca
Classification: 
Non-steroidal aromatase inhibitor; inhibitor of estrogen biosynthesis; antitumor agent
ATC Class: 
L02BG04 - hormone antagonist, enzyme inhibitor
Status: 
active
Notice of Compliance (yyyy/mm/dd): 
Notice of compliance with conditions: 2006/10/17
Presentation: 
tablets: 2.5 mg DIN: 02231384
Comments: 
New indication: first-line therapy in post-menopausal women with advanced breast cancer. For hormonal treatment of advanced/metastatic breast cancer in women with natural or artificially-induced post-menopausal status, who have disease progression following antiestrogen therapy.